Tag:
Jeffrey Leiden
Latest Headlines
Latest Headlines
Interview: Vertex CEO worries about 'hyper-focus' on hep C
No question that Vertex Pharmaceuticals ( $VRTX ) needs another hit to follow its new hepatitis C drug Incivek. But that's just one of the things on the to-do list for incoming CEO Jeffrey Leiden, who
Interview: Vertex CEO concerned about investors' 'hyper-focus' on hep C
Matthew Emmens
On the heels of Vertex Pharmaceuticals' ( $VRTX ) big news last week about changing CEOs next year, FierceBiotech chatted with both current chief executive Matt Emmens
Vertex's new leader expected to diversify
Vertex Pharmaceuticals ( $VRTX ) will be getting its second new leader in two years as it seeks to become a more diversified drug company. Former Abbott Laboratories executive Jeffrey Leiden will
